8-K
Current Report
Viridian Therapeutics, Inc.\DE Filed Acc 0001171843-15-003584
Executive or director change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading f8k_062215.htm…